HK-1

N/A

Report date: 2023/01/14 15:18:46

Base Information

Drug NameHK-1
Drug Alias NameHK-1
ClassificationBiologics > Mitochondrial Therapeutics
Mechanisms of ActionMitochondrial proteins modulators
TargetsMitochondrial proteins
Therapy Area/IndicationsNerve DegenerationRare DiseasesMetabolic Diseases +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCurome Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNerve DegenerationRare DiseasesMetabolic Diseases +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A